NEUROCRINE BIOSCIENCES INC Business Operations Contracts & Agreements

10 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Collaboration and License Agreement dated November 22, 2021 between Heptares Therapeutics Limited and the Company
Collaboration Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
2022
Collaboration and License Agreement dated March 31, 2015 between Mitsubishi Tanabe Pharma Corporation and the Company
Collaboration Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
NY
2021
First Amendment to Collaboration and License Agreement Dated August 31, 2011 between the Company and Abbott International Luxembourg S.a.r.l
Collaboration Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
2021
Collaboration Agreement dated June 15, 2010, by and between Abbott International Luxembourg S.a.r.l. and the Company as amended on August 31, 2011
Collaboration Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
2021
Amendment No. 1 to Collaboration and License Agreement dated June 14, 2019 between Voyager Therapeutics, Inc. and the Company
Collaboration Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
2019
COLLABORATION AGREEMENT dated June 15, 2010 by and between AbbottInternational Luxembourg S.à r.l. and Neurocrine Biosciences, Inc. EXHIBIT INDEX
Collaboration Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
NY
2016
COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
NY
2015
COLLABORATION AGREEMENT dated June 15, 2010 by and between Abbott International Luxembourg S.à r.l. and Neurocrine Biosciences, Inc.
Collaboration Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
2010
Contract Number: 43031148 COLLABORATION AND LICENSE AGREEMENT Dated June 16, 2010 BY AND BETWEEN BOEHRINGER INGELHEIM INTERNATIONAL GmbH AND NEUROCRINE BIOSCIENCES, INC. TABLE OF...
Collaboration Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2010
On December 21, 2006, the Company announced that Wendell Wierenga, Ph.D, Executive Vice President of Research and Development has resigned from the Company. Dr. Wierenga will...
Development Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2006